<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01058889</url>
  </required_header>
  <id_info>
    <org_study_id>352/2006</org_study_id>
    <nct_id>NCT01058889</nct_id>
  </id_info>
  <brief_title>Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes Mellitus</brief_title>
  <acronym>Tele-Diab</acronym>
  <official_title>Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Bank of Austria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to show if telemonitoring and automated feedback regarding
      glucose management, physical activity, blood pressure, and body weight improves treatment of
      patients with insulin dependent Type 2 Diabetes mellitus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this clinical trial 50 patients with insulin dependent type 2 diabetes will be randomised
      in two study arms: monitoring of blood glucose and blood pressure using a telemedical device
      or in an arm with treatment as usual. Patients will the following measurement devices: blood
      glucose, blood pressure. Both devices can communicate with a mobile phone, which will also be
      provided to the patients. The mobile phone will transfer the data to a central, safe server.
      Patients will receive automated reminder/feedback. Caregivers can evaluate the transferred
      data whenever necessary via a web-based access. Data will be presented in tables as well as
      trend figures.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">August 2012</completion_date>
  <primary_completion_date type="Anticipated">August 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>System availability, acceptance, transmission rate</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>HbA1c</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Diabetes Mellitus Type 2</condition>
  <condition>Insulin Resistance</condition>
  <arm_group>
    <arm_group_label>Telemedical device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will receive a blood glucose measurement device and a telemedical device to monitor blood glucose measurements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment as usual</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telemedical device</intervention_name>
    <description>Monitoring of blood glucose,insulin dose, blood pressure, lifestyle factors with the telemedical device. Monitoring of system availability, percentage of data transfer, acceptance.</description>
    <arm_group_label>Telemedical device</arm_group_label>
    <arm_group_label>Treatment as usual</arm_group_label>
    <other_name>mobile phone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetes mellitus Type 2, age 18-70 years, able to use a mobile phone

        Exclusion Criteria:

          -  Pacemaker, intracardial defibrillator, no cure planned within the active study period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernhard Ludvik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karin Schindler, PhD</last_name>
    <phone>+43140400</phone>
    <phone_ext>2032</phone_ext>
    <email>karin.schindler@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bernhard Ludvik, MD</last_name>
    <phone>+43140400</phone>
    <phone_ext>4364</phone_ext>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medical University Vienna, Allgemeines Krankenhaus</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Schindler, PhD</last_name>
      <phone>+43140400</phone>
      <phone_ext>2032</phone_ext>
      <email>karin.schindler@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Bernhard Ludvik, MD</last_name>
      <phone>+43140400</phone>
      <phone_ext>4364</phone_ext>
      <email>bernhard.ludvik@meduniwien.ac.at</email>
    </contact_backup>
    <investigator>
      <last_name>Bernhard Ludvik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 28, 2010</study_first_submitted>
  <study_first_submitted_qc>January 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2010</study_first_posted>
  <last_update_submitted>August 4, 2011</last_update_submitted>
  <last_update_submitted_qc>August 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2011</last_update_posted>
  <responsible_party>
    <name_title>Bernhard Ludvik, MD, Prof.</name_title>
    <organization>Medical University Vienna,</organization>
  </responsible_party>
  <keyword>Diabetes mellitus Type 2</keyword>
  <keyword>Telemedicine</keyword>
  <keyword>Insulin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

